Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction

Junyi Shen, Zhiming Zhao, Wei Shang, Chunli Liu, Beibei Zhang, Lingjie Zhao, Hui Cai Department of Integrated Traditional and Western Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China Abstract: Diabetic cerebral infarction is with poorer prognosis and high rates of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shen J, Zhao Z, Shang W, Liu C, Zhang B, Zhao L, Cai H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/73185ecf4037421cb05817a14afabacc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:73185ecf4037421cb05817a14afabacc
record_format dspace
spelling oai:doaj.org-article:73185ecf4037421cb05817a14afabacc2021-12-02T03:53:32ZGinsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction1178-2013https://doaj.org/article/73185ecf4037421cb05817a14afabacc2017-09-01T00:00:00Zhttps://www.dovepress.com/ginsenoside-rg1-nanoparticle-penetrating-the-blood-brain-barrier-to-im-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Junyi Shen, Zhiming Zhao, Wei Shang, Chunli Liu, Beibei Zhang, Lingjie Zhao, Hui Cai Department of Integrated Traditional and Western Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China Abstract: Diabetic cerebral infarction is with poorer prognosis and high rates of mortality. Ginsenoside Rg1 (Rg1) has a wide variety of therapeutic values for central nervous system (CNS) diseases for the neuron protective effects. However, the blood–brain barrier (BBB) restricts Rg1 in reaching the CNS. In this study, we investigated the therapeutic effects of Rg1 nanoparticle (PHRO, fabricated with γ-PGA, L-PAE (H), Rg1, and OX26 antibody), targeting transferrin receptor, on the diabetes rats complicated with diabetic cerebral infarction in vitro and in vivo. Dynamic light scattering analysis shows the average particle size of PHRO was 79±18 nm and the polydispersity index =0.18. The transmission electron microscope images showed that all NPs were spherical in shape with diameters of 89±23 nm. PHRO released Rg1 with sustained release manner and could promote the migration of cerebrovascular endothelial cells and tube formation and even penetrated the BBB in vitro. PHRO could penetrate the BBB with high concentration in brain tissue to reduce the cerebral infarction volume and promote neuronal recovery in vivo. PHRO was promising to be a clinical treatment of diabetes mellitus with cerebral infarction. Keywords: poly-γ-glutamic acid, ginsenoside Rg1, OX26, blood–brain barrierShen JZhao ZShang WLiu CZhang BZhao LCai HDove Medical PressarticleDiabetic cerebral infarctionGinsenoside Rg1 nanoparticleblood brain barriertransferrin receptorMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6477-6486 (2017)
institution DOAJ
collection DOAJ
language EN
topic Diabetic cerebral infarction
Ginsenoside Rg1 nanoparticle
blood brain barrier
transferrin receptor
Medicine (General)
R5-920
spellingShingle Diabetic cerebral infarction
Ginsenoside Rg1 nanoparticle
blood brain barrier
transferrin receptor
Medicine (General)
R5-920
Shen J
Zhao Z
Shang W
Liu C
Zhang B
Zhao L
Cai H
Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
description Junyi Shen, Zhiming Zhao, Wei Shang, Chunli Liu, Beibei Zhang, Lingjie Zhao, Hui Cai Department of Integrated Traditional and Western Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China Abstract: Diabetic cerebral infarction is with poorer prognosis and high rates of mortality. Ginsenoside Rg1 (Rg1) has a wide variety of therapeutic values for central nervous system (CNS) diseases for the neuron protective effects. However, the blood–brain barrier (BBB) restricts Rg1 in reaching the CNS. In this study, we investigated the therapeutic effects of Rg1 nanoparticle (PHRO, fabricated with γ-PGA, L-PAE (H), Rg1, and OX26 antibody), targeting transferrin receptor, on the diabetes rats complicated with diabetic cerebral infarction in vitro and in vivo. Dynamic light scattering analysis shows the average particle size of PHRO was 79±18 nm and the polydispersity index =0.18. The transmission electron microscope images showed that all NPs were spherical in shape with diameters of 89±23 nm. PHRO released Rg1 with sustained release manner and could promote the migration of cerebrovascular endothelial cells and tube formation and even penetrated the BBB in vitro. PHRO could penetrate the BBB with high concentration in brain tissue to reduce the cerebral infarction volume and promote neuronal recovery in vivo. PHRO was promising to be a clinical treatment of diabetes mellitus with cerebral infarction. Keywords: poly-γ-glutamic acid, ginsenoside Rg1, OX26, blood–brain barrier
format article
author Shen J
Zhao Z
Shang W
Liu C
Zhang B
Zhao L
Cai H
author_facet Shen J
Zhao Z
Shang W
Liu C
Zhang B
Zhao L
Cai H
author_sort Shen J
title Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
title_short Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
title_full Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
title_fullStr Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
title_full_unstemmed Ginsenoside Rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
title_sort ginsenoside rg1 nanoparticle penetrating the blood–brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/73185ecf4037421cb05817a14afabacc
work_keys_str_mv AT shenj ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT zhaoz ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT shangw ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT liuc ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT zhangb ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT zhaol ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
AT caih ginsenosiderg1nanoparticlepenetratingthebloodndashbrainbarriertoimprovethecerebralfunctionofdiabeticratscomplicatedwithcerebralinfarction
_version_ 1718401557253324800